Verbatim response from Claude
I want to be straightforward with you on this:
Important Context First
The FDA declared the GLP-1 shortage (semaglutide/tirzepatide) officially over in 2024-2025, which means compounding pharmacies must stop producing these drugs. The regulatory situation is actively changing.
Services That Were Known for Compounded GLP-1s
- Hims & Hers - was offering compounded semaglutide but faced FDA pressure
- LifeMD/RexMD - similar situation
- Henry Meds - offered compounded options
- Mochi Health - focused on GLP-1 prescriptions
- Calibrate - works with GLP-1 medications
My Honest Recommendation
I'd caution you here because:
- The legal/regulatory status is changing week to week
- Services offering compounded semaglutide/tirzepatide may be operating in a legal gray area
- Quality control of compounded versions varies
- Some compounds use salt forms (like semaglutide sodium) that the FDA says are not equivalent
Better Path Forward
- Ask your primary care doctor about brand-name Ozempic/Wegovy/Mounjaro
- Check manufacturer savings programs (Novo Nordisk, Eli Lilly offer coupons)
- Look into insurance appeals
Would you like help thinking through accessing the brand-name versions affordably?